compound 20 has been researched along with Hypertension, Renal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Essenburg, AD; Kaplan, HR; Meyer, RF; Smith, RD | 1 |
| Almquist, RG; Crase, J; Essenburg, AD; Hoefle, ML; Jennings-White, C; Kaplan, HR; Meyer, RF; Smith, RD | 1 |
2 other study(ies) available for compound 20 and Hypertension, Renal
| Article | Year |
|---|---|
Angiotensin converting enzyme inhibitors: modifications of a tripeptide analogue.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Chemical Phenomena; Chemistry; Hypertension, Renal; Oligopeptides; Rats | 1982 |
Derivatives of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline: effect of changes at positions 2 and 5 of the hexanoic acid portion.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Chemical Phenomena; Chemistry; Dipeptides; Guinea Pigs; Heart Rate; Hypertension, Renal; Male; Rats; Structure-Activity Relationship | 1982 |